Affordable Access

deepdyve-link
Publisher Website

Effect of xylitol tablets with and without red propolis on salivary parameters, dental biofilm and sensory acceptability of adolescents: a randomized crossover clinical trial.

Authors
  • Martins, Mariana Leonel1
  • Monteiro, Amanda Souza Nunes1
  • Vieira, Thiago Isidro1
  • Guimarães, Maria Bárbara de Carvalho Tor...1
  • de Abreu, Letícia Coli Louvisse2
  • Cabral, Lucio Mendes2
  • Cavalcanti, Yuri Wanderley3
  • Maia, Lucianne Cople1
  • Fonseca-Gonçalves, Andréa1
  • 1 Department of Pediatric Dentistry and Orthodontics, School of Dentistry, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. , (Brazil)
  • 2 Department of Pharmaceutics, Faculty of Pharmacy, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. , (Brazil)
  • 3 Department of Clinical and Social Dentistry, Universidade Federal da Paraíba, João Pessoa, PB, Brazil. , (Brazil)
Type
Published Article
Journal
Biofouling
Publisher
Informa UK (Taylor & Francis)
Publication Date
Nov 01, 2020
Volume
36
Issue
10
Pages
1182–1195
Identifiers
DOI: 10.1080/08927014.2020.1858063
PMID: 33334195
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

The effect of xylitol tablets with (XPT) and without (XT) red propolis on salivary parameters, dental biofilm and acceptability of adolescents was evaluated through a blinded randomized crossover clinical trial. Healthy volunteers were allocated in the XPT and XT groups with a 30-day washout period for consumption of two tablets/dayfor seven days. An increase in salivary parameters was only observed immediately after tablet consumption, without differences between XPT and XT. The results for total microorganisms were similar, but XT was better in controlling Streptococcus spp. Rothia dentocariosa and Streptococcus salivarius were the most frequent in the biofilm and saliva, respectively. XPT and XT showed similar acceptability, with the highest purchase intention for XT. Although propolis did not enhance the properties of XT, further studies testing different protocols and follow-up are necessary; XT controlled Streptococcus spp. in biofilms, which demonstrate its potential for clinical application.

Report this publication

Statistics

Seen <100 times